Skip to main content

Father Johns Medicine

NDC 45728-444 · Oakhurst Company

Generic nameDextromethorphan HBr
Dosage formLIQUID
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE
Strength10 mg/5mL
Pharmacologic classSigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryOTC MONOGRAPH DRUG

Packages

45728-444-94 — 1 CONTAINER in 1 CARTON (45728-444-94) / 118 mL in 1 CONTAINER

45728-444-98 — 1 CONTAINER in 1 CONTAINER (45728-444-98) / 237 mL in 1 CONTAINER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42507-727 — brompheniramine maleate, dextromethorphan hydrobromide, 42507-763 — Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl, 42507-811 — acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, 42507-812 — dextromethorphan HBr, guaifenesin, 42507-861 — acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride, 43063-801 — GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, 43598-114 — Guaifenesin and Dextromethorphan HBR, 43598-115 — Guaifenesin and Dextromethorphan HBR, 43598-231 — Guaifenesin and Dextromethorphan HBR, 43598-232 — Guaifenesin and Dextromethorphan HBR, 45728-445 — Nasal Decongestant, 45737-105 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 45737-249 — Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine HCL, 45737-250 — CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, 45737-251 — Dextromethorphan Hydrobromide, Guaifenesin, 45802-433 — dextromethorphan polistirex, 46122-136 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 46122-141 — dextromethorphan polistirex, 46122-198 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 46122-245 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, +1967 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.